CardioComm Solutions（EKGG.F）株式概要CardioComm Solutions, Inc.は、世界中の医療および消費者市場向けに、心電図（ECG）および外来不整脈モニタリングシステムに関連する先進的なソフトウェアおよびハードウェア製品、中核的な検査室読み取りサービスを開発している。 詳細EKGG.F ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析キャッシュランウェイが1年未満である 収益が 100 万ドル未満 ( CA$272K )過去5年間で収益は年間48.8%減少しました。 マイナスの株主資本 +2 さらなるリスクすべてのリスクチェックを見るEKGG.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW469,165 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA469,165 investors already sharing narrativesYour Fair ValueUS$Current PriceUS$0.011990.0% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-1m2m2016201920222025202620282031Revenue CA$138.7kEarnings CA$17.5kAdvancedSet Fair ValueView all narrativesCardioComm Solutions, Inc. 競合他社Healthcare TriangleSymbol: NasdaqCM:HCTIMarket cap: US$2.6miSpecimenSymbol: NasdaqCM:ISPCMarket cap: US$5.5mSCWorxSymbol: OTCPK:WORX.DMarket cap: US$493.8kBiotricitySymbol: OTCPK:BTCYMarket cap: US$2.2m価格と性能株価の高値、安値、推移の概要CardioComm Solutions過去の株価現在の株価CA$0.01152週高値CA$0.01152週安値CA$0.004ベータ-1.321ヶ月の変化0%3ヶ月変化n/a1年変化172.50%3年間の変化65.15%5年間の変化-60.89%IPOからの変化-97.00%最新ニュースお知らせ • Jan 27CardioComm Solutions, Inc., Annual General Meeting, Mar 25, 2026CardioComm Solutions, Inc., Annual General Meeting, Mar 25, 2026. Location: northyork, ontario, Canadaお知らせ • Oct 15CardioComm Solutions, Inc., Annual General Meeting, Dec 11, 2024CardioComm Solutions, Inc., Annual General Meeting, Dec 11, 2024. Location: ontario, north york Canadaお知らせ • Jan 09Cardiocomm Solutions, Inc. Announces CFO ChangesCardioComm Solutions, Inc. announce the appointment of Mr. Robert Caines as Chief Financial Officer of the Company. Effective January 8, 2024, Mr. Caines assumed the role of CFO, replacing Mr. Etienne Grima who served as interim CFO since August 3, 2023. Mr. Caines will also continue to serve as Chairman of the Board of Directors and Mr. Grima will continue to serve as the Company's Chief Executive Officer.お知らせ • Dec 16CardioComm Solutions, Inc. Resumes Full Operations Following Cyber AttackCardioComm Solutions, Inc. confirmed to its customers and stakeholders that following a recent cyber attack the Company has successfully restored its systems and resumed full-scale operations stronger than ever. On July 25, 2023, the Company announced a cyber attack took place which disrupted CardioComm's digital infrastructure and interrupted customer access to ECG reading and remote patient monitoring services. Promptly responding to the breach, the Company engaged cybersecurity experts, including KPMG-EGYDE, and initiated a comprehensive assessment and fortification of its systems to mitigate any potential vulnerabilities. The rigorous measures taken during the recovery phase included implementing security protocols, conducting employee training sessions to reinforce cybersecurity awareness, and collaborating with industry experts to reinforce the Company's digital resilience. As a result of these efforts, CardioComm confirms the successful restoration of all affected systems and services with completed investigations showing no evidence of data access and /or data exfiltration from CardioComm's IT environment. Post-attack investigations have found no evidence of threat actor activity or presence in CardioComm's newly restored IT environment. Given the cyber attack's medium risk of harm classification, the Company proactively and duly submitted a report to the Office of Privacy Commissioner of Canada (PIPEDA) which was reviewed and successfully closed without further reviews. The Company has also engaged support for continued dark web search /monitoring as well as credit and identity monitoring for a two-year period by Transunion. Transunion is a major credit reporting, fraud, and analytics solutions provider across the finance, retail, telecommunications, utilities, government and insurance sectors. Moving forward, CardioComm remains steadfastly committed to maintaining the highest standards of cybersecurity to safeguard its operations and the interests of its stakeholders. In keeping with this commitment, the Company has completed ISO 27001 certification and entered into a service agreement with Oracle for Oracle Cloud Infrastructure (OCI) services that assure business continuity and transparent disaster recovery for its production infrastructure and development/test and corporate environments. SOC provides CardioComm high-performance compute capabilities and storage capacity in a flexible overlay virtual network that is securely accessible from CardioComm's on-premises network that will provide customers with high availability with no downtime. SOC also provides a number of security features such as data encryption by default at rest and in motion, and auto detection and remediation of security issues. Oracle manages more than 80 global, regional and industry-specific programs to provide third-party attestations like SOC, ISO, HIPAA, and FedRAMP, and advisories for standards like GxP, NIST, GDPR and FISC. This is the first year that CardioComm has been certified under ISO 27001, an international standard that focuses on information security management, providing a framework for establishing, implementing, maintaining, and continually improving an information security management system (ISMS) within an organization. Achieving ISO 27001 certification involved a thorough audit by an independent certification body to ensure compliance with the standard's requirements. Certification demonstrates CardioComm's commitment to managing and protecting its information assets and to provide assurances to its customers and stakeholders in the health industry about the level of performance of CardioComm's security practices.お知らせ • Oct 14CardioComm Solutions, Inc., Annual General Meeting, Dec 13, 2023CardioComm Solutions, Inc., Annual General Meeting, Dec 13, 2023.お知らせ • Jan 31CardioComm Solutions, Inc. Announces Executive ChangesCardioComm Solutions, Inc. announced that Mr. Daniel Grima joined the board of the Company on December 20, 2022, when he was elected as a director of the Company by the Company's shareholders at the Company's AGM. Mr. D. Grima was a founding partner of Cornerstone Research Group, a global leader in Health Economics and Market Access research and communications that specialized in establishing product value for the medical device and pharmaceutical industries. Cornerstone was acquired by EVERSANA Life Science Services LLC following which Mr. D. Grima served for three years as Senior Vice President and General Manager. Each of Mr. Simi Grosman and Mr. Steven Benyo did not stand for re-election as directors at the 2022 AGM, as they will be focusing on other interests. Mr. Benyo will continue to act as an advisor to the Company. The Company's board and management thank Mr. Grosman and Mr. Benyo for their contributions to the Company and wish them well in the future.最新情報をもっと見るRecent updatesお知らせ • Jan 27CardioComm Solutions, Inc., Annual General Meeting, Mar 25, 2026CardioComm Solutions, Inc., Annual General Meeting, Mar 25, 2026. Location: northyork, ontario, Canadaお知らせ • Oct 15CardioComm Solutions, Inc., Annual General Meeting, Dec 11, 2024CardioComm Solutions, Inc., Annual General Meeting, Dec 11, 2024. Location: ontario, north york Canadaお知らせ • Jan 09Cardiocomm Solutions, Inc. Announces CFO ChangesCardioComm Solutions, Inc. announce the appointment of Mr. Robert Caines as Chief Financial Officer of the Company. Effective January 8, 2024, Mr. Caines assumed the role of CFO, replacing Mr. Etienne Grima who served as interim CFO since August 3, 2023. Mr. Caines will also continue to serve as Chairman of the Board of Directors and Mr. Grima will continue to serve as the Company's Chief Executive Officer.お知らせ • Dec 16CardioComm Solutions, Inc. Resumes Full Operations Following Cyber AttackCardioComm Solutions, Inc. confirmed to its customers and stakeholders that following a recent cyber attack the Company has successfully restored its systems and resumed full-scale operations stronger than ever. On July 25, 2023, the Company announced a cyber attack took place which disrupted CardioComm's digital infrastructure and interrupted customer access to ECG reading and remote patient monitoring services. Promptly responding to the breach, the Company engaged cybersecurity experts, including KPMG-EGYDE, and initiated a comprehensive assessment and fortification of its systems to mitigate any potential vulnerabilities. The rigorous measures taken during the recovery phase included implementing security protocols, conducting employee training sessions to reinforce cybersecurity awareness, and collaborating with industry experts to reinforce the Company's digital resilience. As a result of these efforts, CardioComm confirms the successful restoration of all affected systems and services with completed investigations showing no evidence of data access and /or data exfiltration from CardioComm's IT environment. Post-attack investigations have found no evidence of threat actor activity or presence in CardioComm's newly restored IT environment. Given the cyber attack's medium risk of harm classification, the Company proactively and duly submitted a report to the Office of Privacy Commissioner of Canada (PIPEDA) which was reviewed and successfully closed without further reviews. The Company has also engaged support for continued dark web search /monitoring as well as credit and identity monitoring for a two-year period by Transunion. Transunion is a major credit reporting, fraud, and analytics solutions provider across the finance, retail, telecommunications, utilities, government and insurance sectors. Moving forward, CardioComm remains steadfastly committed to maintaining the highest standards of cybersecurity to safeguard its operations and the interests of its stakeholders. In keeping with this commitment, the Company has completed ISO 27001 certification and entered into a service agreement with Oracle for Oracle Cloud Infrastructure (OCI) services that assure business continuity and transparent disaster recovery for its production infrastructure and development/test and corporate environments. SOC provides CardioComm high-performance compute capabilities and storage capacity in a flexible overlay virtual network that is securely accessible from CardioComm's on-premises network that will provide customers with high availability with no downtime. SOC also provides a number of security features such as data encryption by default at rest and in motion, and auto detection and remediation of security issues. Oracle manages more than 80 global, regional and industry-specific programs to provide third-party attestations like SOC, ISO, HIPAA, and FedRAMP, and advisories for standards like GxP, NIST, GDPR and FISC. This is the first year that CardioComm has been certified under ISO 27001, an international standard that focuses on information security management, providing a framework for establishing, implementing, maintaining, and continually improving an information security management system (ISMS) within an organization. Achieving ISO 27001 certification involved a thorough audit by an independent certification body to ensure compliance with the standard's requirements. Certification demonstrates CardioComm's commitment to managing and protecting its information assets and to provide assurances to its customers and stakeholders in the health industry about the level of performance of CardioComm's security practices.お知らせ • Oct 14CardioComm Solutions, Inc., Annual General Meeting, Dec 13, 2023CardioComm Solutions, Inc., Annual General Meeting, Dec 13, 2023.お知らせ • Jan 31CardioComm Solutions, Inc. Announces Executive ChangesCardioComm Solutions, Inc. announced that Mr. Daniel Grima joined the board of the Company on December 20, 2022, when he was elected as a director of the Company by the Company's shareholders at the Company's AGM. Mr. D. Grima was a founding partner of Cornerstone Research Group, a global leader in Health Economics and Market Access research and communications that specialized in establishing product value for the medical device and pharmaceutical industries. Cornerstone was acquired by EVERSANA Life Science Services LLC following which Mr. D. Grima served for three years as Senior Vice President and General Manager. Each of Mr. Simi Grosman and Mr. Steven Benyo did not stand for re-election as directors at the 2022 AGM, as they will be focusing on other interests. Mr. Benyo will continue to act as an advisor to the Company. The Company's board and management thank Mr. Grosman and Mr. Benyo for their contributions to the Company and wish them well in the future.株主還元EKGG.FUS Healthcare ServicesUS 市場7D0%11.0%1.0%1Y172.5%-23.4%18.4%株主還元を見る業界別リターン: EKGG.F過去 1 年間で-23.4 % の収益を上げたUS Healthcare Services業界を上回りました。リターン対市場: EKGG.F過去 1 年間で18.4 % の収益を上げたUS市場を上回りました。価格変動Is EKGG.F's price volatile compared to industry and market?EKGG.F volatilityEKGG.F Average Weekly Movementn/aHealthcare Services Industry Average Movement9.9%Market Average Movement7.2%10% most volatile stocks in US Market16.2%10% least volatile stocks in US Market3.1%安定した株価: EKGG.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のEKGG.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト1989n/aEtienne Grimacardiocommsolutions.comCardioComm Solutions, Inc.は、世界中の医療および消費者市場向けに、心電図（ECG）および外来不整脈モニタリング・システムに関する先進的なソフトウェアおよびハードウェア製品、中核的な検査室読み取りサービスを開発している。GEMSモバイルECG、GEMSモバイルRPM、HeartCheck CardiBeat - モバイルECGデバイス、HeartCheck SMARTモニタリングなどの消費者向け健康モニタリング製品を提供。また、GEMS Sirona、GEMS WIN、Trident Pro 40Lなどの医療従事者向けモニタリング製品も提供している。CardioComm Solutions, Inc.は1989年に設立され、カナダのトロントに本社を置いています。もっと見るCardioComm Solutions, Inc. 基礎のまとめCardioComm Solutions の収益と売上を時価総額と比較するとどうか。EKGG.F 基礎統計学時価総額US$1.42m収益（TTM）-US$379.68k売上高(TTM)US$195.16k7.3xP/Sレシオ-3.7xPER（株価収益率EKGG.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計EKGG.F 損益計算書（TTM）収益CA$272.16k売上原価CA$50.41k売上総利益CA$221.75kその他の費用CA$751.23k収益-CA$529.49k直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.0027グロス・マージン81.48%純利益率-194.55%有利子負債／自己資本比率-96.4%EKGG.F の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/13 12:19終値2026/07/09 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CardioComm Solutions, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jan 27CardioComm Solutions, Inc., Annual General Meeting, Mar 25, 2026CardioComm Solutions, Inc., Annual General Meeting, Mar 25, 2026. Location: northyork, ontario, Canada
お知らせ • Oct 15CardioComm Solutions, Inc., Annual General Meeting, Dec 11, 2024CardioComm Solutions, Inc., Annual General Meeting, Dec 11, 2024. Location: ontario, north york Canada
お知らせ • Jan 09Cardiocomm Solutions, Inc. Announces CFO ChangesCardioComm Solutions, Inc. announce the appointment of Mr. Robert Caines as Chief Financial Officer of the Company. Effective January 8, 2024, Mr. Caines assumed the role of CFO, replacing Mr. Etienne Grima who served as interim CFO since August 3, 2023. Mr. Caines will also continue to serve as Chairman of the Board of Directors and Mr. Grima will continue to serve as the Company's Chief Executive Officer.
お知らせ • Dec 16CardioComm Solutions, Inc. Resumes Full Operations Following Cyber AttackCardioComm Solutions, Inc. confirmed to its customers and stakeholders that following a recent cyber attack the Company has successfully restored its systems and resumed full-scale operations stronger than ever. On July 25, 2023, the Company announced a cyber attack took place which disrupted CardioComm's digital infrastructure and interrupted customer access to ECG reading and remote patient monitoring services. Promptly responding to the breach, the Company engaged cybersecurity experts, including KPMG-EGYDE, and initiated a comprehensive assessment and fortification of its systems to mitigate any potential vulnerabilities. The rigorous measures taken during the recovery phase included implementing security protocols, conducting employee training sessions to reinforce cybersecurity awareness, and collaborating with industry experts to reinforce the Company's digital resilience. As a result of these efforts, CardioComm confirms the successful restoration of all affected systems and services with completed investigations showing no evidence of data access and /or data exfiltration from CardioComm's IT environment. Post-attack investigations have found no evidence of threat actor activity or presence in CardioComm's newly restored IT environment. Given the cyber attack's medium risk of harm classification, the Company proactively and duly submitted a report to the Office of Privacy Commissioner of Canada (PIPEDA) which was reviewed and successfully closed without further reviews. The Company has also engaged support for continued dark web search /monitoring as well as credit and identity monitoring for a two-year period by Transunion. Transunion is a major credit reporting, fraud, and analytics solutions provider across the finance, retail, telecommunications, utilities, government and insurance sectors. Moving forward, CardioComm remains steadfastly committed to maintaining the highest standards of cybersecurity to safeguard its operations and the interests of its stakeholders. In keeping with this commitment, the Company has completed ISO 27001 certification and entered into a service agreement with Oracle for Oracle Cloud Infrastructure (OCI) services that assure business continuity and transparent disaster recovery for its production infrastructure and development/test and corporate environments. SOC provides CardioComm high-performance compute capabilities and storage capacity in a flexible overlay virtual network that is securely accessible from CardioComm's on-premises network that will provide customers with high availability with no downtime. SOC also provides a number of security features such as data encryption by default at rest and in motion, and auto detection and remediation of security issues. Oracle manages more than 80 global, regional and industry-specific programs to provide third-party attestations like SOC, ISO, HIPAA, and FedRAMP, and advisories for standards like GxP, NIST, GDPR and FISC. This is the first year that CardioComm has been certified under ISO 27001, an international standard that focuses on information security management, providing a framework for establishing, implementing, maintaining, and continually improving an information security management system (ISMS) within an organization. Achieving ISO 27001 certification involved a thorough audit by an independent certification body to ensure compliance with the standard's requirements. Certification demonstrates CardioComm's commitment to managing and protecting its information assets and to provide assurances to its customers and stakeholders in the health industry about the level of performance of CardioComm's security practices.
お知らせ • Oct 14CardioComm Solutions, Inc., Annual General Meeting, Dec 13, 2023CardioComm Solutions, Inc., Annual General Meeting, Dec 13, 2023.
お知らせ • Jan 31CardioComm Solutions, Inc. Announces Executive ChangesCardioComm Solutions, Inc. announced that Mr. Daniel Grima joined the board of the Company on December 20, 2022, when he was elected as a director of the Company by the Company's shareholders at the Company's AGM. Mr. D. Grima was a founding partner of Cornerstone Research Group, a global leader in Health Economics and Market Access research and communications that specialized in establishing product value for the medical device and pharmaceutical industries. Cornerstone was acquired by EVERSANA Life Science Services LLC following which Mr. D. Grima served for three years as Senior Vice President and General Manager. Each of Mr. Simi Grosman and Mr. Steven Benyo did not stand for re-election as directors at the 2022 AGM, as they will be focusing on other interests. Mr. Benyo will continue to act as an advisor to the Company. The Company's board and management thank Mr. Grosman and Mr. Benyo for their contributions to the Company and wish them well in the future.
お知らせ • Jan 27CardioComm Solutions, Inc., Annual General Meeting, Mar 25, 2026CardioComm Solutions, Inc., Annual General Meeting, Mar 25, 2026. Location: northyork, ontario, Canada
お知らせ • Oct 15CardioComm Solutions, Inc., Annual General Meeting, Dec 11, 2024CardioComm Solutions, Inc., Annual General Meeting, Dec 11, 2024. Location: ontario, north york Canada
お知らせ • Jan 09Cardiocomm Solutions, Inc. Announces CFO ChangesCardioComm Solutions, Inc. announce the appointment of Mr. Robert Caines as Chief Financial Officer of the Company. Effective January 8, 2024, Mr. Caines assumed the role of CFO, replacing Mr. Etienne Grima who served as interim CFO since August 3, 2023. Mr. Caines will also continue to serve as Chairman of the Board of Directors and Mr. Grima will continue to serve as the Company's Chief Executive Officer.
お知らせ • Dec 16CardioComm Solutions, Inc. Resumes Full Operations Following Cyber AttackCardioComm Solutions, Inc. confirmed to its customers and stakeholders that following a recent cyber attack the Company has successfully restored its systems and resumed full-scale operations stronger than ever. On July 25, 2023, the Company announced a cyber attack took place which disrupted CardioComm's digital infrastructure and interrupted customer access to ECG reading and remote patient monitoring services. Promptly responding to the breach, the Company engaged cybersecurity experts, including KPMG-EGYDE, and initiated a comprehensive assessment and fortification of its systems to mitigate any potential vulnerabilities. The rigorous measures taken during the recovery phase included implementing security protocols, conducting employee training sessions to reinforce cybersecurity awareness, and collaborating with industry experts to reinforce the Company's digital resilience. As a result of these efforts, CardioComm confirms the successful restoration of all affected systems and services with completed investigations showing no evidence of data access and /or data exfiltration from CardioComm's IT environment. Post-attack investigations have found no evidence of threat actor activity or presence in CardioComm's newly restored IT environment. Given the cyber attack's medium risk of harm classification, the Company proactively and duly submitted a report to the Office of Privacy Commissioner of Canada (PIPEDA) which was reviewed and successfully closed without further reviews. The Company has also engaged support for continued dark web search /monitoring as well as credit and identity monitoring for a two-year period by Transunion. Transunion is a major credit reporting, fraud, and analytics solutions provider across the finance, retail, telecommunications, utilities, government and insurance sectors. Moving forward, CardioComm remains steadfastly committed to maintaining the highest standards of cybersecurity to safeguard its operations and the interests of its stakeholders. In keeping with this commitment, the Company has completed ISO 27001 certification and entered into a service agreement with Oracle for Oracle Cloud Infrastructure (OCI) services that assure business continuity and transparent disaster recovery for its production infrastructure and development/test and corporate environments. SOC provides CardioComm high-performance compute capabilities and storage capacity in a flexible overlay virtual network that is securely accessible from CardioComm's on-premises network that will provide customers with high availability with no downtime. SOC also provides a number of security features such as data encryption by default at rest and in motion, and auto detection and remediation of security issues. Oracle manages more than 80 global, regional and industry-specific programs to provide third-party attestations like SOC, ISO, HIPAA, and FedRAMP, and advisories for standards like GxP, NIST, GDPR and FISC. This is the first year that CardioComm has been certified under ISO 27001, an international standard that focuses on information security management, providing a framework for establishing, implementing, maintaining, and continually improving an information security management system (ISMS) within an organization. Achieving ISO 27001 certification involved a thorough audit by an independent certification body to ensure compliance with the standard's requirements. Certification demonstrates CardioComm's commitment to managing and protecting its information assets and to provide assurances to its customers and stakeholders in the health industry about the level of performance of CardioComm's security practices.
お知らせ • Oct 14CardioComm Solutions, Inc., Annual General Meeting, Dec 13, 2023CardioComm Solutions, Inc., Annual General Meeting, Dec 13, 2023.
お知らせ • Jan 31CardioComm Solutions, Inc. Announces Executive ChangesCardioComm Solutions, Inc. announced that Mr. Daniel Grima joined the board of the Company on December 20, 2022, when he was elected as a director of the Company by the Company's shareholders at the Company's AGM. Mr. D. Grima was a founding partner of Cornerstone Research Group, a global leader in Health Economics and Market Access research and communications that specialized in establishing product value for the medical device and pharmaceutical industries. Cornerstone was acquired by EVERSANA Life Science Services LLC following which Mr. D. Grima served for three years as Senior Vice President and General Manager. Each of Mr. Simi Grosman and Mr. Steven Benyo did not stand for re-election as directors at the 2022 AGM, as they will be focusing on other interests. Mr. Benyo will continue to act as an advisor to the Company. The Company's board and management thank Mr. Grosman and Mr. Benyo for their contributions to the Company and wish them well in the future.
